Follow us
Alta Life Sciences
  • About us
  • Our strategy
  • News
Main Menu

Portfolio

Ona Therapeutics
Inbiomotion
Sanifit
Accure Therapeutics
Peptomyc
Inbrain Neuroelectronics
Mediktor
Binx Health
deepUll

Latest news

  • Journal of Medical Economics study shows significant cost savings via MAF Test® – guided adjuvant bisphosphonate therapy for early-stage breast cancer September 18, 2025
  • INBRAIN Neuroelectronics Announces Collaboration to Advance Graphene-Based Brain-Computer Interfaces September 15, 2025
  • Peptomyc Announces Leadership Transition to Support Next Phase of Growth July 4, 2025
  • deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection April 30, 2025
  • Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials April 7, 2025

Our Partner

© 2025 Alta Life Sciences. All rights reserved.
Proudly powered by WordPress | Theme: THBusiness By ThemezHut

Insert/edit link

Enter the destination URL

Or link to existing content

    No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.